N-Terminal proBNP Levels and Tissue Doppler Echocardiography in Acute Rheumatic Carditis
Table 1
Data of the studied groups.
Variable
Acute rheumatic carditis
Quiescent RHD
Control group
Age (yrs)
Mean ± SD (range)
(8.0–15)
(6.0–16)
(6.0–16)
Males
10
18
17
Weight (Kg)
Mean ± SD (range)
(25–85)
(20–70)
(17–55)
Height (cm)
Mean ± SD (range)
(125–163)
(109–171)
(107–19)
NYHA
I
4
24
0
II
1
9
0
III
3
0
0
IV
8
0
0
Arthritis
12
0
0
Chorea
2
0
0
Medications
Furosemide
12
5
0
Spironolactone
4
0
0
Digoxin
10
4
0
Captopril
10
15
0
Haloperidol
2
0
0
Prednisolone
16
0
0
Acetyl salicylic acid
16
0
0
Valve lesions
Isolated MR
4
18
0
Isolated AR
1
0
0
MR and AR
11
15
0
Severe MS
0
2
0
Severity of valve lesions
MR
Mild
3
23
0
Moderate
7
9
0
Severe
5
1
0
AR
Mild
7
10
0
Moderate
3
5
0
Severe
2
0
Pericardial effusion
11
1
0
Mean LV strain (%)
Mean ± SD (range)
(12–49)
(14–28)
(17–27.7)
Mean LV time to peak strain (sec)
Mean ± SD (range)
(0.14–0.36)
(0.31–0.35)
(0.3–0.37)
NT-proBNP (fmol/mL)
Mean ± SD (range)
(130–950)
(65–650)
(65–200)
Abbreviations: BSA: body surface area; NT-proBNP: N-terminal pro-brain-type natriuretic peptide; NYHA: New York Heart Association functional class; RBCs: red blood cells; RF: rheumatic fever; SD: standard deviation; WBCs: white blood cells.
